Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Single-Molecule Real-Time Sequencing (SMRT) Market Forecast Highlighting Growth From $3.63 Billion To $4.9 Billion

Fueled by burgeoning genomic research endeavors, the expanding embrace of next-generation sequencing technologies, a heightened need for comprehensive whole genome sequencing, escalating investments within the life sciences sector, and significant strides in sequencing chemistry, the single-molecule real-time sequencing (smrt) market experienced robust expansion historically. This momentum is projected to continue, with the market value anticipated to ascend from $3.36 billion in 2025 to $3.63 billion in 2026, exhibiting a compound annual growth rate of 8.1%.

The market for single-molecule real-time (SMRT) sequencing is poised for significant expansion in the coming years, projected to reach $4.9 billion by 2030, reflecting a compound annual growth rate of 7.8%. This anticipated growth trajectory is underpinned by several key factors, including the escalating adoption of precision medicine, a mounting need for large-scale genomic data, the broadening spectrum of clinical genomics applications, the increasing incorporation of AI-powered bioinformatics, and augmented investments in cutting-edge sequencing technologies. During this forecast period, notable trends are expected to shape the landscape, such as a greater embrace of long-read sequencing, the expanded utilization of SMRT sequencing for identifying structural genetic variations, a heightened demand for precise epigenetic analyses, the development of more streamlined real-time sequencing processes, and a more concentrated effort towards resolving intricate genomic structures.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19696&type=smp

Single-Molecule Real-Time Sequencing (SMRT) Market Demand Drivers: What Is Fueling Industry Growth?

The expansion of the single-molecule real-time sequencing (SMRT) market is anticipated to be fueled by the escalating need for precision medicine. This personalized approach to healthcare designs treatment and intervention strategies customized to each patient, taking into account their genetic makeup, environmental exposures, and lifestyle choices. Driving the increasing adoption of personalized medicine are breakthroughs in genomic technologies that facilitate more precise and individualized therapies, coupled with a heightened focus on patient-specific care to achieve superior health outcomes. SMRT technology plays a crucial role in advancing precision medicine by delivering comprehensive and accurate genomic and epigenetic data, thereby improving diagnostic capabilities, enabling tailored treatments, and ultimately enhancing patient results. A notable illustration is the U.S. Food and Drug Administration’s approval of 18 new personalized medicines in 2023, representing approximately 38% of all newly authorized therapeutic molecular entities, as reported by the Personalized Medicine Coalition (PMC) in May 2025. Consequently, the growing demand for precision medicine is a significant catalyst for the expansion of the single-molecule real-time sequencing (SMRT) market.

The increasing prevalence of genetic disorders is poised to accelerate the growth trajectory of the single-molecule real-time sequencing (SMRT) market. These health conditions stem from alterations in an individual’s genetic material, either inherited or acquired through mutations, and can manifest as challenges in physical development, metabolic function, or overall well-being. Factors such as heightened public awareness, sophisticated diagnostic tools, and influences like environmental conditions and advanced parental age contribute to the rising rates of genetic disorders. Within the realm of genetic disorders, SMRT is instrumental in generating precise, long-read DNA sequences that facilitate the identification of intricate mutations and structural variations often overlooked by conventional techniques. As an example, the Gene People, a UK-based charity supporting individuals with genetic disorders, stated in March 2024 that more than 6,000 distinct genetic conditions are currently recognized, with new ones being identified regularly. In the United Kingdom specifically, one in every 25 children is impacted, leading to an annual tally of 30,000 new diagnoses and a population of over 2.4 million people living with these conditions. Therefore, the escalating incidence of genetic disorders serves as a key driver for the expansion of the single-molecule real-time sequencing (SMRT) market.

Single-Molecule Real-Time Sequencing (SMRT) Market Segmentation Trends And Revenue Drivers

The single-molecule real-time sequencing (smrt) market covered in this report is segmented –

1) By Product: Consumable, Instrument, Services

2) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications

3) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End-Users

Subsegments:

1) By Consumable: Reagents, Sample Preparation Kits, Flow Cells

2) By Instrument: SMRT Sequencers, Accessories, Software

3) By Services: Data Analysis Services, Sequencing Services, Technical Support Services

Single-Molecule Real-Time Sequencing (SMRT) Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the single-molecule real-time sequencing (smrt) market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen N.V., BGI Group, 10x Genomics Inc., Ginkgo Bioworks Inc., Oxford Nanopore Technologies Limited, Genewiz Inc., Pacific Biosciences of California Inc., Macrogen Inc., Element Biosciences Inc., Asuragen Inc., BioNano Genomics Inc., Zymo Research Corporation, Dovetail Genomics LLC, SeqWell Inc., Paragon Genomics Inc., Nabsys Inc., Eurofins Scientific SE, Novogene Corporation

Access The Complete Single-Molecule Real-Time Sequencing (SMRT) Market Report:

https://www.thebusinessresearchcompany.com/report/single-molecule-real-time-sequencing-smrt-global-market-report

Single-Molecule Real-Time Sequencing (SMRT) Market Geographic Analysis: Where Is Demand Growing The Fastest?

North Americawas the largest region in the single-molecule real-time sequencing (SMRT) market in 2025. The regions covered in the single-molecule real-time sequencing (smrt) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model